STATE OF WISCONSIN INVESTMENT BOARD - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 152 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$201,856
-56.4%
12,800
-46.3%
0.00%0.0%
Q2 2023$463,255
-27.0%
23,830
+6.5%
0.00%
-50.0%
Q1 2023$634,921
-32.9%
22,380
-30.9%
0.00%
-33.3%
Q4 2022$946,818
+143.4%
32,392
+120.2%
0.00%
+200.0%
Q3 2022$389,000
-26.5%
14,711
+23.6%
0.00%0.0%
Q2 2022$529,000
-23.7%
11,903
-15.0%
0.00%0.0%
Q1 2022$693,000
-2.8%
14,0000.0%0.00%0.0%
Q4 2021$713,000
-8.7%
14,0000.0%0.00%
-50.0%
Q3 2021$781,000
+30.4%
14,0000.0%0.00%
+100.0%
Q2 2021$599,000
+2.6%
14,0000.0%0.00%0.0%
Q1 2021$584,000
-19.6%
14,000
-10.3%
0.00%
-50.0%
Q4 2020$726,000
-2.3%
15,600
-10.9%
0.00%0.0%
Q3 2020$743,000
+9.7%
17,500
+24.1%
0.00%0.0%
Q2 2020$677,000
+4.3%
14,1000.0%0.00%0.0%
Q1 2020$649,000
-25.0%
14,100
-2.1%
0.00%0.0%
Q4 2019$865,000
+6.1%
14,4000.0%0.00%0.0%
Q3 2019$815,000
+1.6%
14,4000.0%0.00%0.0%
Q2 2019$802,000
+12.6%
14,400
+2.1%
0.00%0.0%
Q1 2019$712,000
+62.2%
14,100
+29.4%
0.00%
+100.0%
Q4 2018$439,000
-40.3%
10,900
+2.8%
0.00%
-50.0%
Q3 2018$735,000
-8.4%
10,6000.0%0.00%0.0%
Q2 2018$802,000
+153.8%
10,600
+76.7%
0.00%
+100.0%
Q1 2018$316,000
-1.6%
6,0000.0%0.00%0.0%
Q4 2017$321,000
-10.3%
6,0000.0%0.00%0.0%
Q3 2017$358,000
-24.3%
6,0000.0%0.00%
-50.0%
Q2 2017$473,0006,0000.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Tri Locum Partners LP 94,922$4,063,0001.33%
Smith, Graham & Co., Investment Advisors, LP 277,572$11,880,0001.05%
Krensavage Asset Management, LLC 70,804$3,030,0001.03%
BRANDES INVESTMENT PARTNERS, LP 716,873$30,682,0000.68%
GLOBEFLEX CAPITAL L P 42,357$1,813,0000.33%
Zebra Capital Management LLC 6,472$277,0000.32%
Capital Impact Advisors, LLC 19,276$825,0000.27%
Hein Park Capital Management LP 31,977$1,369,0000.26%
CHARTWELL INVESTMENT PARTNERS, LLC 195,340$8,361,0000.25%
Stanley-Laman Group, Ltd. 24,000$1,027,0000.15%
View complete list of EAGLE PHARMACEUTICALS INC shareholders